Clinical Trial Update: TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of TQB3616 capsules for dedifferentiated liposarcoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma

Drugs mentioned

• TQB3616

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Dedifferentiated Liposarcoma | Phase 2 | Status: TERMINATED